To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min DraftKings will move its ...

Dec 8 (Reuters) - Recursion Pharma (RXRX.O), opens new tab, which uses artificial intelligence to discover new drug candidates, said on Monday its experimental oral drug helped reduce abnormal growths ...

Shares of Recursion Pharmaceuticals, Inc. (NASDAQ: RXRX) are trading higher Monday after the pharmaceutical company reported positive data from an ongoing trial. What To Know: Recursion ...

Hasbro's plan is to open its new office in the Boston Seaport by the end of 2026 The temporary office will also be in the Seaport A Hasbro spokeswoman wouldn't say if the temporary office is open to ...

Fans eagerly waiting for a new Boston Blue episode on November 28 were disappointed to discover a rerun of Fire Country on CBS. This naturally invites intrigue: has the Blue Bloods' spin-off gone on ...

Recursion Pharmaceuticals' work could change the way that drugs are developed. Its pipeline features some exciting candidates, and it's partnering with major drugmakers. However, Recursion still needs ...

Jeffrey is a freelance features writer at Collider. He is an MPA-accredited entertainment journalist and a Tomatometer-approved critic based in the LA area. He graduated from the University of Texas ...

Andrew Joseph covers health, medicine, and the biopharma industry in Europe. You can reach Andrew on Signal at drewqjoseph.45. LONDON — In the year-plus since Najat Khan joined the AI-focused drug ...

Kevin Skarupa recently spoke to the sixth-graders at New Boston Central School. Kevin Skarupa recently spoke to the sixth-graders at New Boston Central School. No weather data available ...

Recursion Pharmaceuticals, Inc. leverages AI to accelerate drug discovery, offering both a licensing platform and an internal drug development pipeline. RXRX faces heavy competition, ongoing operating ...

After a challenging 12 years trying to use AI to create new medicines, cofounder Chris Gibson stepped down as CEO last week. Can R&D chief and new CEO Najat Khan turn it around? In 2014, Recursion ...